 |
Editor’s Comment |
|
|
News |
|
 |
Strategy |
| |
Risk management delivering value for pharmaceutical facilities – Mark Boult, DNV |
| |
|
 |
Regulatory |
|
Drug metabolism in the intestine – Esther van de Kerkhof, NOTOX
Managing your regulatory information: Address challenges and achieve success |
|
Jim Nichols, Liquents, a Thomson Scientific business |
| |
|
 |
Drug discovery/development/delivery |
|
Counterfeit prescription drugs and the threat they pose to global health – Masters UK
Topical drug development: Clinical programmes in dermatology |
|
Dr Betsy Hughes-Formella, bioskin |
| |
|
 |
Clinical research |
|
Putting the focus on patient care – Jenny Hone |
|
Beyond CDISC: Taking the next stop in clinical data standardisation
– Kit Howard, Kestrel Consultants |
|
Why patient enrolment in Russia and Ukraine is up to 25 times higher than in the West
– David Passov, ClinStar |
| |
|
 |
Logistics |
|
Role of pre-wholesalers in
generic pharmaceutical
manufacturers’ demand
chain management strategy |
| |
|
 |
Manufacturing |
|
Integrated building management and process control – Walfried Laibacher, Honeywell Lifesciences |
|
Protecting consumers from counterfeit drugs – FDA |
|
Consumer is king: To buy or not to buy– Inga Daugeliene, Dintag |
|
Authenticity, tamper protection and tracing of genuine pharmaceutical products for the
pharmaceutical industry – Thomas Völcker, Schreiner ProSecure |
|
Wipes for lifescience cleanrooms: How to select the best wipes for the job
– Karen Rossington, Shield Medicare |
|
Leveling the playing field: A primer for CMOs – Bikash Chatterjee, Pharmatech Associates |
 |
Country Focus: India |
|
Pharma India – Dr Charles Horth |
|
India’s place in the global clinical development sector – Dr Nermeen Varawalla, PRA International |
| |
|
 |
Shows and events |
|
The world’s premier clinical
professionals meet in Madrid |
| |
|
 |
Recruitment |
|
Recruitment process outsourcing in the lifescience industry – Dr Charles Horth |
